Global Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market Size & Share, Growth, Trends, and Forecast 2017 - 2025

The report "Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025", has been prepared based on an in-depth market analysis with inputs from industry experts.

The objectives of this study are as follows:

To define, describe, and forecast the "Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors)" market by type, application, component, delivery model, end user, and region

To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the market size of market segments with respect to the four key regions: North America, Europe, Asia, and the Rest of the World (RoW)

To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies

Get Sample Copy Of This Report @ https://www.marketresearchreports.biz/sample/sample/1506826

Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles. Hence, it is widely targeted for therapeutic treatments of Parkinson’s and Huntington’s disease. VMAT2 inhibitors block VMAT2 proteins and control the neurotransmission activity, thereby reducing the unwanted body movements caused by Huntington’s disease and tardive dyskinesia. VMAT2 inhibitors are widely used for the treatment of uncontrollable involuntary, repetitive body movements caused due to tardive dyskinesia and Huntington’s disease.

The global vesicular monoamine transporter-2 inhibitors market is driven primarily by rise in incidence of the diseases mentioned above. Huntington’s disease is a progressive brain disorder that causes involuntary body movement, loss of recognition ability, and emotional problems. Prevalence of this disease is high in the developed countries, especially in Europe. An estimated five to seven people per 100,000 are affected by Huntington’s disease in countries in the West. High prevalence of Huntington’s disease has been observed in Venezuela, where around 700 people per 100,000 have the disease. Tardive dyskinesia is a side effect of antipsychotic medications used for the treatment of schizophrenia and other mental health disorders. In the U.S., this disease occurs in 15% to 30% patients who have received long-term neuroleptic medication. Moreover, the investigational studies for the discovery of novel therapeutics using VMAT2 inhibitor to treat methamphetamine abuse are likely to boost demand during the forecast period. However, side effects of VMAT 2 inhibitors such as sleepiness, dry mouth, constipation, and heart conduction changes are likely to hamper the growth of the VMAT2 inhibitors market.

View Report @ https://www.marketresearchreports.biz/reports/1506826/vesicular-monoamine-transporter-inhibitors-vmat-market-research-reports

The global VMAT2 inhibitors market can be segmented based on application and region. In terms of application, the global market can categorized into Huntington’s disease and tardive dyskinesia. The tardive dyskinesia segment is projected to account for high market share by 2025. The segment is anticipated to record exponential growth rate during the forecast period. People with schizophrenia, bipolar disorders, and other neuropsychiatric disorders undergoing long-term medical treatments with antipsychotic medication are more likely to develop symptoms of tardive dyskinesia.

Geographically, the global VMAT2 inhibitors market can be segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. North America is expected to hold significant share of the global market by 2025. Large market share of the region is attributed to increase in number of patients with bipolar diseases, schizophrenia, and Huntington’s disease in this region. Europe is likely to record high CAGR during the forecast period. High prevalence of Huntington’s disease and rise in incidence of tardive dyskinesia are projected to drive the market in the region during the forecast period. The market in Asia Pacific is anticipated to expand at a moderate growth rate during the forecast period.

Key players operating in the global VMAT2 inhibitors market include Tocris Bioscience, Neurocrine Biosciences, Inc., Teva Pharmaceuticals Industries Ltd., EUSA Pharma (UK) Limited, and Lundbeck, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request For Enquiry @ https://www.marketresearchreports.biz/sample/enquiry/1506826

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Check Discount @ https://www.marketresearchreports.biz/sample/checkdiscount/1506826

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market

About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.